BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24797185)

  • 1. Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophy.
    Solders M; Martin DA; Andersson C; Remberger M; Andersson T; Ringdén O; Solders G
    Bone Marrow Transplant; 2014 Aug; 49(8):1046-51. PubMed ID: 24797185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access.
    Fumagalli F; Calbi V; Natali Sora MG; Sessa M; Baldoli C; Rancoita PMV; Ciotti F; Sarzana M; Fraschini M; Zambon AA; Acquati S; Redaelli D; Attanasio V; Miglietta S; De Mattia F; Barzaghi F; Ferrua F; Migliavacca M; Tucci F; Gallo V; Del Carro U; Canale S; Spiga I; Lorioli L; Recupero S; Fratini ES; Morena F; Silvani P; Calvi MR; Facchini M; Locatelli S; Corti A; Zancan S; Antonioli G; Farinelli G; Gabaldo M; Garcia-Segovia J; Schwab LC; Downey GF; Filippi M; Cicalese MP; Martino S; Di Serio C; Ciceri F; Bernardo ME; Naldini L; Biffi A; Aiuti A
    Lancet; 2022 Jan; 399(10322):372-383. PubMed ID: 35065785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients.
    Groeschel S; Kühl JS; Bley AE; Kehrer C; Weschke B; Döring M; Böhringer J; Schrum J; Santer R; Kohlschütter A; Krägeloh-Mann I; Müller I
    JAMA Neurol; 2016 Sep; 73(9):1133-40. PubMed ID: 27400410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.
    Biffi A; Montini E; Lorioli L; Cesani M; Fumagalli F; Plati T; Baldoli C; Martino S; Calabria A; Canale S; Benedicenti F; Vallanti G; Biasco L; Leo S; Kabbara N; Zanetti G; Rizzo WB; Mehta NA; Cicalese MP; Casiraghi M; Boelens JJ; Del Carro U; Dow DJ; Schmidt M; Assanelli A; Neduva V; Di Serio C; Stupka E; Gardner J; von Kalle C; Bordignon C; Ciceri F; Rovelli A; Roncarolo MG; Aiuti A; Sessa M; Naldini L
    Science; 2013 Aug; 341(6148):1233158. PubMed ID: 23845948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.
    Sessa M; Lorioli L; Fumagalli F; Acquati S; Redaelli D; Baldoli C; Canale S; Lopez ID; Morena F; Calabria A; Fiori R; Silvani P; Rancoita PM; Gabaldo M; Benedicenti F; Antonioli G; Assanelli A; Cicalese MP; Del Carro U; Sora MG; Martino S; Quattrini A; Montini E; Di Serio C; Ciceri F; Roncarolo MG; Aiuti A; Naldini L; Biffi A
    Lancet; 2016 Jul; 388(10043):476-87. PubMed ID: 27289174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic Stem Cell Transplantation with Mesenchymal Stromal Cells in Children with Metachromatic Leukodystrophy.
    Cabanillas Stanchi KM; Böhringer J; Strölin M; Groeschel S; Lenglinger K; Treuner C; Kehrer C; Laugwitz L; Bevot A; Kaiser N; Schumm M; Lang P; Handgretinger R; Krägeloh-Mann I; Müller I; Döring M
    Stem Cells Dev; 2022 Apr; 31(7-8):163-175. PubMed ID: 35323019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report.
    Boucher AA; Miller W; Shanley R; Ziegler R; Lund T; Raymond G; Orchard PJ
    Orphanet J Rare Dis; 2015 Aug; 10():94. PubMed ID: 26245762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atidarsagene autotemcel for metachromatic leukodystrophy.
    Messina M; Gissen P
    Drugs Today (Barc); 2023 Feb; 59(2):63-70. PubMed ID: 36811406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hematopoietic cell transplantation for adult metachromatic leukodystrophy: a case series.
    Riedel A; Faul C; Reuss K; Schröder JC; Lang PJ; Lengerke C; Weissert N; Hengel H; Gröschel S; Schoels L; Bethge WA
    Blood Adv; 2024 Mar; 8(6):1504-1508. PubMed ID: 38330194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy in metachromatic leukodystrophy.
    Sevin C; Cartier-Lacave N; Aubourg P
    Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S128-31. PubMed ID: 20040324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biochemical study of 29 Brazilian patients with metachromatic leukodystrophy.
    Artigalás O; Lagranha VL; Saraiva-Pereira ML; Burin MG; Lourenço CM; van der Linden H; Santos ML; Rosemberg S; Steiner CE; Kok F; de Souza CF; Jardim LB; Giugliani R; Schwartz IV
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S257-62. PubMed ID: 20596894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metachromatic leukodystrophy: Disease spectrum and approaches for treatment.
    van Rappard DF; Boelens JJ; Wolf NI
    Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):261-73. PubMed ID: 25987178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding caregiver descriptions of initial signs and symptoms to improve diagnosis of metachromatic leukodystrophy.
    Eichler F; Sevin C; Barth M; Pang F; Howie K; Walz M; Wilds A; Calcagni C; Chanson C; Campbell L
    Orphanet J Rare Dis; 2022 Oct; 17(1):370. PubMed ID: 36195888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of Early Juvenile Onset Metachromatic Leukodystrophy After Unrelated Cord Blood Transplantation: A Case Series and Review of the Literature.
    Chen X; Gill D; Shaw P; Ouvrier R; Troedson C
    J Child Neurol; 2016 Mar; 31(3):338-44. PubMed ID: 26187619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro correction of ARSA deficiency in human skin fibroblasts from metachromatic leukodystrophy patients after treatment with microencapsulated recombinant cells.
    Lagranha VL; Baldo G; de Carvalho TG; Burin M; Saraiva-Pereira ML; Matte U; Giugliani R
    Metab Brain Dis; 2008 Dec; 23(4):469-84. PubMed ID: 18797988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy.
    Al-Saady M; Beerepoot S; Plug BC; Breur M; Galabova H; Pouwels PJW; Boelens JJ; Lindemans C; van Hasselt PM; Matzner U; Vanderver A; Bugiani M; van der Knaap MS; Wolf NI
    Ann Clin Transl Neurol; 2023 Jul; 10(7):1146-1159. PubMed ID: 37212343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report.
    Meuleman N; Vanhaelen G; Tondreau T; Lewalle P; Kwan J; Bennani J; Martiat P; Lagneaux L; Bron D
    Haematologica; 2008 Jan; 93(1):e11-3. PubMed ID: 18166768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of brain oligodendrocytes by AAVrh.10 intracerebral gene therapy in metachromatic leukodystrophy mice.
    Piguet F; Sondhi D; Piraud M; Fouquet F; Hackett NR; Ahouansou O; Vanier MT; Bieche I; Aubourg P; Crystal RG; Cartier N; Sevin C
    Hum Gene Ther; 2012 Aug; 23(8):903-14. PubMed ID: 22642214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematopoietic stem cell transplantation does not retard disease progression in the psycho-cognitive variant of late-onset metachromatic leukodystrophy.
    Smith NJ; Marcus RE; Sahakian BJ; Kapur N; Cox TM
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S471-5. PubMed ID: 21080229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing therapeutic approaches for metachromatic leukodystrophy.
    Patil SA; Maegawa GH
    Drug Des Devel Ther; 2013; 7():729-45. PubMed ID: 23966770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.